French research reveals hydroxchilorok does not help patients with coronary

Hydroxiklorok, a drug that was supported by President Trump, did not help patients hospitalised with coronarys; rather, he accompanied heart complications, according to a new study. This provides evidence that hydrocyclorina does not apparently treat patients with Coddy-19,” said Dr. Paul Off, an infectious disease specialist at Children's Hospital [...]
Hydroxiklorok, a drug that was supported by President Trump, did not help patients hospitalised with coronarys; rather, he accompanied heart complications, according to a new study.
This provides evidence that hydrocyclorina does not apparently treat patients with Coddy-19,” said Dr. Paul Off, an infectious disease specialist at the Philadelphia Children's Hospital, reports CNN, broadcasts news.net.
Even worse, there have been side effects caused by the toxicity of heart medicine that asked to stop”, Dr. Offfit.
The study was published on a pre-set server on Tuesday and was not praised by specialist's colleagues.
In the study, among the 84 patients who received hydroxiclorine, 20.2% were admitted to the intensive care unit (ICU) or died within seven days. Among the 97 patients who did not take the medicine, 22.1% were admitted to the ICU or died.
Looking only at the deaths, 2.8% of patients who received hydroxhyrium died, and 4.6% of patients who did not receive it died.












